デフォルト表紙
市場調査レポート
商品コード
1006027

医療用解凍システム市場の成長機会・成長予測 (2020-2027年):サンプルタイプ (血液・胚・卵子・精液)・エンドユーザー (血液バンク・病院・組織バンク・製薬&バイオテクノロジー企業など)・地域別

Medical Thawing System Market by Sample Type (Blood, Embryo, Ovum, and Semen) and End User (Blood Banks, Hospitals, Tissue Banks, Pharmaceutical & Biotech Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2020-2027

出版日: | 発行: Allied Market Research | ページ情報: 英文 186 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
医療用解凍システム市場の成長機会・成長予測 (2020-2027年):サンプルタイプ (血液・胚・卵子・精液)・エンドユーザー (血液バンク・病院・組織バンク・製薬&バイオテクノロジー企業など)・地域別
出版日: 2021年03月24日
発行: Allied Market Research
ページ情報: 英文 186 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療用解凍システムの市場規模は予測期間中11.6%のCAGRで推移し、2019年の1億6582万米ドルから、2027年には2億7917万ドルの規模に成長すると予測されています。

慢性疾患の増加による血液や血漿製品への需要の拡大、技術の進歩による解凍プロセスの簡素化などの要因が同市場の成長を推進しています。また、血漿提供に対する意識の高まり、政府の取り組みの拡大、システム発売数・契約数の増加、胚ドナーの増加、第三者を介する生殖に対する意識の高まりなどの要因も市場成長を後押ししています。一方で、自動化コストの高さが市場成長を一定程度妨げています。

当レポートでは、世界の医療用解凍システムの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、サンプルタイプ・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
  • ポーターのファイブフォース分析
  • 主要企業の位置付け
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析
  • COVID-19:影響分析

第4章 市場分析・予測:サンプルタイプ別

  • 血液
  • 卵子
  • 精液
    • 主要市場動向・成長機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第5章 市場分析・予測:エンドユーザー別

  • 血液バンク
  • 病院
  • 組織バンク
  • 製薬・バイオテクノロジー企業
  • その他
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向・成長機会
    • 市場規模・予測:サンプルタイプ別
    • 市場規模・予測:エンドユーザー別
    • 市場規模・予測:国別

第7章 企業プロファイル

  • BARKEY GMBH & CO. KG
  • BOEKEL SCIENTIFIC
  • BIOLIFE SOLUTIONS INC.
  • CARDINAL HEALTH INC.
  • GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
  • HELMER SCIENTIFIC
  • SARTORIUS AG
  • SARSTEDT AG & CO. KG
  • TERUMO CORPORATION
  • THERMO FISHER SCIENTIFIC, INC.
図表

LIST OF TABLES

  • TABLE 01.GLOBAL MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027 ($MILLION)
  • TABLE 02.BLODD MEDICAL THAWING SYSTEM MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 03.EMBRYO MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 04.OVUM MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 05.SEMEN MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06.GLOBAL MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027 ($MILLION)
  • TABLE 07.BLOOD BANK MEDICAL THAWING SYSTEM MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.HOSPITAL MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.TISSUE BANK MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.PHARMACEUTICAL AND BIOTECH COMPANIES MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.OTHERS MEDICAL THAWING SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.MEDICAL THAWING SYSTEM MARKET, BY REGION, 2019-2027, ($MILLION)
  • TABLE 13.NORTH AMERICA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 14.NORTH AMERICA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 15.NORTH AMERICA MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019-2027, ($MILLION)
  • TABLE 16.U.S. MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 17.U.S. MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 18.CANADA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 19.CANADA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 20.MEXICO MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 21.MEXICO MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 22.EUROPE MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 23.EUROPE MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 24.EUROPE MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019-2027, ($MILLION)
  • TABLE 25.GERMANY MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 26.GERMANY MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 27.FRANCE MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 28.FRANCE MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 29.UK MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 30.UK MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 31.ITALY MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 32.ITALY MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 33.SPAIN MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 34.SPAIN MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 35.REST OF EUROPE MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 36.REST OF EUROPE MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 37.ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 38.ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 39.ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019-2027, ($MILLION)
  • TABLE 40.JAPAN MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 41.JAPAN MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 42.CHINA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 43.CHINA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 44.AUSTRALIA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 45.AUSTRALIA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 46.INDIA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 47.INDIA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 48.SOUTH KOREA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 49.SOUTH KOREA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 50.REST OF ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 51.REST OF ASIA-PACIFIC MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 52.LAMEA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 53.LAMEA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 54.LAMEA MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019-2027, ($MILLION)
  • TABLE 55.BRAZIL MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 56.BRAZIL MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 57.SAUDI ARABIA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 58.SAUDI ARABIA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 59.SOUTH AFRICA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 60.SOUTH AFRICA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 61.REST OF LAMEA MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE, 2019-2027, ($MILLION)
  • TABLE 62.REST OF LAMEA MEDICAL THAWING SYSTEM MARKET, BY END USER, 2019-2027, ($MILLION)
  • TABLE 63.BARKEY: COMPANY SNAPSHOT
  • TABLE 64.BARKEY: OPERATING SEGMENTS
  • TABLE 65.BAYER: PRODUCT PORTFOLIO
  • TABLE 66.BOEKEL SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 67.BOEKEL SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 68.ELI LILLY: PRODUCT PORTFOLIO
  • TABLE 69.BIOLIFE SOLUTIONS: COMPANY SNAPSHOT
  • TABLE 70.BIOLIFE SOLUTIONS: OPERATING SEGMENTS
  • TABLE 71.BIOLIFE SOLUTIONS: PRODUCT PORTFOLIO
  • TABLE 72.CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 73.CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 74.CARDINAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 75.GE: COMPANY SNAPSHOT
  • TABLE 76.GE: OPERATING SEGMENTS
  • TABLE 77.GE: PRODUCT PORTFOLIO
  • TABLE 78.HELMER: COMPANY SNAPSHOT
  • TABLE 79.HELMER: OPERATING BUSINESS SEGMENTS
  • TABLE 80.HELMER: PRODUCT PORTFOLIO
  • TABLE 81.SARTORIUS: COMPANY SNAPSHOT
  • TABLE 82.SARTORIUS: OPERATING BUSINESS SEGMENTS
  • TABLE 83.SARTORIUS: PRODUCT PORTFOLIO
  • TABLE 84.SARSTEDT GROUP: COMPANY SNAPSHOT
  • TABLE 85.SARSTEDT GROUP: OPERATING SEGMENTS
  • TABLE 86.SARSTEDT GROUP: PRODUCT PORTFOLIO
  • TABLE 87.TERUMO: COMPANY SNAPSHOT
  • TABLE 88.TERUMO: OERATING SEGMENT
  • TABLE 89.TERUMO: PRODUCT PORTFOLIO
  • TABLE 90.THERMO FISHER: COMPANY SNAPSHOT
  • TABLE 91.THERMO FISHER.: OPERATING SEGMENTS
  • TABLE 92.THERMO FISHER.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.GLOBAL MEDICAL THAWING SYSTEM MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKETS
  • FIGURE 03.LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 04.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 05.HIGH THREAT OF SUBSTITUTES
  • FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07.MODERATE INTENSITY OF RIVALRY
  • FIGURE 08.TOP PLAYER POSITIONING, 2019
  • FIGURE 09.IMPACT ANALYSIS
  • FIGURE 10.COMPARATIVE ANALYSIS OF BLOOD MEDICAL THAWING SYSTEM MARKET, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 11.COMPARATIVE ANALYSIS OF EMBRYO MEDICAL THAWING SYSTEM, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 12.COMPARATIVE ANALYSIS OF OVUM MEDICAL THAWING SYSTEM, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 13.COMPARATIVE ANALYSIS OF SEMEN MEDICAL THAWING SYSTEM, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 14.COMPARATIVE COUNTRY ANALYSIS OF BLOOD BANK MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
  • FIGURE 15.COMPARATIVE COUNTRY ANALYSIS OF HOSPITAL MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
  • FIGURE 16.COMPARATIVE COUNTRY ANALYSIS OF TISSUE BANK MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
  • FIGURE 17.COMPARATIVE COUNTRY ANALYSIS OF PHAMACEUTICAL AND BIOTECH COMPANIES MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
  • FIGURE 18.COMPARATIVE COUNTRY ANALYSIS OF OTHERS MEDICAL THAWING SYSTEM, 2019 & 2027 (%)
  • FIGURE 19.BIOLIFE SOLUTIONS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 20.BIOLIFE SOLUTIONS: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 21.BIOLIFE SOLUTIONS: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 22.CARDINAL HEALTH: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 23.CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 24.CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 25.GE: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 26.GE: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 27.GE: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 28.MYLAN: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 29.MYLAN: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 30.SARTORIUS: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 31.SARTORIUS: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 32.SARTORIUS: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 33.TERUMO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 34.TERUMO: REVENUE SHARE BY SEGMENT, 2019 (%)
  • FIGURE 35.TERUMO: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 36.THERMO FISHER: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 37.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 38.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)
目次
Product Code: LI_2110924 / A10559

The global medical thawing system market was valued at $165.82 million in 2019 and is expected to reach $279.17 million by 2027 with a CAGR of 11.6% during the forecast period.

Thawing system is the process developed to defrost biological samples in cell biology research. Biology research is used in drug discovery, bio-banking, assisted reproduction, cellular therapy, and regenerative medicine. This system is required to transport and store pharmaceutical products & services in the biopharmaceutical industry. Automated thawing instruments are designed to rapidly thaw live biological contents of a cryogenic vial with high reproducibility and minimal risk of contamination.

Increase in incidences of chronic disease lead to demand for blood and plasma products and technological advancements to simplify the process of thawing, which propels the market growth. In addition, rise in awareness and government initiatives toward plasma donation, rise in launches and agreement of medical thawing systems, increase in number of embryo donors, and rise in awareness of third-party reproduction further drive the market growth. However, high cost of automation hinders the market growth. Moreover, direct need for novel medicinal inventions to push adoption of thawing systems is expected to provide lucrative market growth during the forecast period.

The medical thawing system market is divided on the basis of sample type, end user, and region. By sample, the market is segmented into blood, embryo, ovum, and semen. On the basis of end user, it is segmented into blood banks, hospitals, tissue banks, pharmaceutical and biotech companies, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competitive rivalry in the global medical thawing system market was observed at high level as major market participants are focused on the adoption of growth strategies such as product launches, agreement and acquisitions to gain substantial share in the competitive market.

Prominent companies operating in the global medical thawing system market include Barkey GmbH & Co. KG, Boekel Scientific, BioLife Solutions Inc, Cardinal Health, Inc., General Electric Company, Helmer Scientific, Sartorius AG, Sarstedt AG & Co. KG, Terumo Corporation, and Thermo Fisher Scientific Inc.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the global medical thawing system market with current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
  • Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key Market Segments

By Sample Type

  • Blood
  • Embryo
  • Ovum
  • Semen

By End User

  • Blood Banks
  • Hospitals
  • Tissue Banks
  • Pharmaceutical and Biotech Companies
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
  • List of key players profiled in the report
  • Barkey GmbH & Co. KG
  • Boekel Scientific
  • BioLife Solutions Inc.
  • Cardinal Health, Inc.
  • General Electric Company
  • Helmer Scientific
  • Sartorius AG
  • Sarstedt AG & Co. KG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • List of the other key players (not included in the report) includesARCOX TMC GROUP, LABCOLD, Abbott, Medtronic, Brainlab AG, Varian Medical Systems, Inc., Olympus Corporation and KARL STORZ SE & Co. KG.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning, 2019
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in incidences of chronic disease leading to demand for blood and plasma products
      • 3.5.1.2.Technological advancement to ease and simply the process of thawing
      • 3.5.1.3.Rise in awareness and government initiative towards the plasma donation
      • 3.5.1.1.Rise in launches and agreement of medical thawing systems
      • 3.5.1.2.Increase in number of embryo donors and rise in awareness of third party reproduction
    • 3.5.2.Restraints
      • 3.5.2.1.High cost of the automation
    • 3.5.3.Opportunities
      • 3.5.3.1.Dire need for novel medicinal inventions to push adoption of thawing systems
    • 3.5.4.Impact analysis
  • 3.6.Impact analysis of COVID-19 on medical thawing system market

CHAPTER 4:MEDICAL THAWING SYSTEM MARKET, BY SAMPLE TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Blood
    • 4.2.1.Key developments and tends
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market analysis, by country
  • 4.3.Embryo
    • 4.3.1.Key developments and tends
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market analysis, by country
  • 4.4.Ovum
    • 4.4.1.Key market trends and opportunity
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market analysis, by country
  • 4.5.Semen
    • 4.5.1.Key market trends and opportunity
    • 4.5.2.Market size and forecast, by region
    • 4.5.3.Market analysis, by country

CHAPTER 5:MEDICAL THAWING SYSTEM MARKET, BY END USER

  • 5.1.Overview
    • 5.1.1.Market size and forecast, by end user
  • 5.2.Blood Banks
    • 5.2.1.Market size and forecast, by region
    • 5.2.2.Market analysis, by country
  • 5.3.Hospitals
    • 5.3.1.Market size and forecast, by region
    • 5.3.2.Market analysis, by country
  • 5.4.Tissue Banks
    • 5.4.1.Market size and forecast, by region
    • 5.4.2.Market analysis, by country
  • 5.5.Pharmaceutical and Biotech Companies
    • 5.5.1.Market size and forecast, by region
    • 5.5.2.Market analysis, by country
  • 5.6.Others
    • 5.6.1.Market size and forecast, by region
    • 5.6.2.Market analysis, by country

CHAPTER 6:MEDICAL THAWING SYSTEM MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key market trends and opportunities
    • 6.2.2.North America market size and forecast, by sample type
    • 6.2.3.North America market size and forecast, by end user
    • 6.2.4.North America market size and forecast, by country
    • 6.2.5.U.S.
      • 6.2.5.1.U.S. market size and forecast, by sample type
      • 6.2.5.2.U.S. market size and forecast, by end user
    • 6.2.6.Canada
      • 6.2.6.1.Canada market size and forecast, by sample type
      • 6.2.6.2.Canada market size and forecast, by end user
    • 6.2.7.Mexico
      • 6.2.7.1.Mexico market size and forecast, by sample type
      • 6.2.7.2.Mexico market size and forecast, by end user
  • 6.3.Europe
    • 6.3.1.Key market trends and opportunities
    • 6.3.2.Europe market size and forecast, by sample type
    • 6.3.3.Europe market size and forecast, by end user
    • 6.3.4.Europe market size and forecast, by country
    • 6.3.5.Germany
      • 6.3.5.1.Germany market size and forecast, by sample type
      • 6.3.5.2.Germany market size and forecast, by end user
    • 6.3.6.France
      • 6.3.6.1.France market size and forecast, by sample type
      • 6.3.6.2.France market size and forecast, by end user
    • 6.3.7.UK
      • 6.3.7.1.UK market size and forecast, by sample type
      • 6.3.7.2.UK market size and forecast, by end user
    • 6.3.8.Italy
      • 6.3.8.1.Italy market size and forecast, by sample type
      • 6.3.8.2.Italy market size and forecast, by end user
    • 6.3.9.Spain
      • 6.3.9.1.Spain market size and forecast, by sample type
      • 6.3.9.2.Spain market size and forecast, by end user
    • 6.3.10.Rest of Europe
      • 6.3.10.1.Rest of Europe market size and forecast, by sample type
      • 6.3.10.2.Rest of Europe market size and forecast, by end user
  • 6.4.Asia-Pacific
    • 6.4.1.Key market trends and opportunities
    • 6.4.2.Asia-Pacific market size and forecast, by sample type
    • 6.4.3.Asia-Pacific market size and forecast, by end user
    • 6.4.4.Asia-Pacific market size and forecast, by country
    • 6.4.5.Japan
      • 6.4.5.1.Japan market size and forecast, by sample type
      • 6.4.5.2.Japan market size and forecast, by end user
    • 6.4.6.China
      • 6.4.6.1.China market size and forecast, by sample type
      • 6.4.6.2.China market size and forecast, by end user
    • 6.4.7.Australia
      • 6.4.7.1.Australia market size and forecast, by sample type
      • 6.4.7.2.Australia market size and forecast, by end user
    • 6.4.8.India
      • 6.4.8.1.India market size and forecast, by sample type
      • 6.4.8.2.India market size and forecast, by end user
    • 6.4.9.South Korea
      • 6.4.9.1.South Korea market size and forecast, by sample type
      • 6.4.9.2.South Korea market size and forecast, by end user
    • 6.4.10.Rest of Asia-Pacific
      • 6.4.10.1.Rest of Asia-Pacific market size and forecast, by sample type
      • 6.4.10.2.Rest of Asia-Pacific market size and forecast, by end user
  • 6.5.LAMEA
    • 6.5.1.Key market trends and opportunities
    • 6.5.2.LAMEA market size and forecast, by sample type
    • 6.5.3.LAMEA market size and forecast, by end user
    • 6.5.4.LAMEA market size and forecast, by country
    • 6.5.5.Brazil
      • 6.5.5.1.Brazil market size and forecast, by sample type
      • 6.5.5.2.Brazil market size and forecast, by end user
    • 6.5.6.Saudi Arabia
      • 6.5.6.1.Saudi Arabia market size and forecast, by sample type
      • 6.5.6.2.Saudi Arabia market size and forecast, by end user
    • 6.5.7.South Africa
      • 6.5.7.1.South Africa market size and forecast, by sample type
      • 6.5.7.2.South Africa market size and forecast, by end user
    • 6.5.8.Rest of LAMEA
      • 6.5.8.1.Rest of LAMEA market size and forecast, by sample type
      • 6.5.8.2.Rest of LAMEA market size and forecast, by end user

CHAPTER 7:COMPANY PROFILES

  • 7.1.BARKEY GMBH & CO. KG
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating business segments
    • 7.1.4.Product portfolio
  • 7.2.BOEKEL SCIENTIFIC
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Product portfolio
  • 7.3.BIOLIFE SOLUTIONS INC.
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating business segments
    • 7.3.4.Product portfolio
    • 7.3.5.Business performance
  • 7.4.CARDINAL HEALTH INC.
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Product portfolio
    • 7.4.5.Business performance
  • 7.5.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
    • 7.5.1.Company overview
    • 7.5.2.Company snapshot
    • 7.5.3.Operating business segments
    • 7.5.4.Product portfolio
    • 7.5.5.Business performance
  • 7.6.HELMER SCIENTIFIC
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product portfolio
    • 7.6.5.Business performance
  • 7.7.SARTORIUS AG
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Operating business segments
    • 7.7.4.Product portfolio
    • 7.7.5.Business performance
  • 7.8.SARSTEDT AG & CO. KG
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating business segments
    • 7.8.4.Product portfolio
  • 7.9.TERUMO CORPORATION
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product portfolio
    • 7.9.5.Business performance
  • 7.10.THERMO FISHER SCIENTIFIC, INC.
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Product portfolio
    • 7.10.5.Business performance